MOPEAD coordinates survey on GP attitudes to Alzheimer's disease treatment across five European



The MOPEAD Project has coordinated a large scale anonymous survey on General Practitioners' (GP) attitudes towards the early diagnosis of Alzheimer's disease (AD) and the availability of current treatments.


The survey aims to get a better understanding of how GP's handle the diagnosis of mild cognitive impairment (MCI) or dementia and how useful it is to make such a diagnosis in a more timely manner.


With over 200 responses so far from over 5 different European countries including Spain, Sweden, The Netherlands, Slovenia and Germany, the survey will support MOPEAD's aim to move the AD environment towards earlier diagnosis. Currently only 40-50% of people living with dementia will have received a diagnosis. An earlier diagnosis would provide an opportunity for intervention giving people with Alzheimer's disease and their families "more time" and the potential for inclusion in Clinical Trails.[1]


We hope the survey will highlight what GP's need from policy makers to deliver a step-change in how public health services provide timely diagnosis and support to those suffering from Alzheimer's disease, a figure which is expected to rise to 131 million world wide by 2050.[2]


You can read more about Alzheimer's disease on our website here: https://www.mopead.eu/support.


Or check out our infographics created by our MOPEAD team of experts to guide you through your memory health: https://www.mopead.eu/infographics

[1] World Alzheimer Report 2016: https://www.alz.co.uk/research/WorldAlzheimerReport2011.pdf

[2]UN Dept of Economic and Social Affairs: https://esa.un.org/unpd/wpp/DataQuery/

Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square